Steven C. Quay
Chief Executive Officer, Adhera Therapeutics, Inc.
Companies
- Atossa Therapeutics (United States)President Mar 18, 2015 to now1
- Atossa Therapeutics (United States)Board member Nov 7, 2012 to now2
- Atossa Therapeutics (United States)Chief executive officer Nov 7, 2012 to now2
- Adhera Therapeutics, Inc.Board member Mar 20, 2009 to Mar 20, 20093
- Adhera Therapeutics, Inc.Chair Jan 3, 2006 to Jun 12, 20084
- Adhera Therapeutics, Inc.Chief executive officer Jan 3, 2006 to Apr 2, 20084
- Adhera Therapeutics, Inc.President Jan 3, 2006 to Sep 28, 20074
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Atossa Therapeutics (United States) ATOS89,521 shares5$227.3K at $2.54Mar 31, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 27, 2026Granted 65,000 shares of Atossa Therapeutics (United States)5
- Jan 20, 2026Granted 331,674 shares of Atossa Therapeutics (United States)6
- Jan 20, 2026Granted 325,203 shares of Atossa Therapeutics (United States)7
- May 21, 2025Bought 11,239 shares at $0.88 of Atossa Therapeutics (United States)8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARAdhera Therapeutics, Inc., Chair
- 5
- 6SEC EDGARForm 4 filed Jan 30, 2026
- 7SEC EDGARForm 4 filed Jan 22, 2026
- 8SEC EDGARForm 4 filed May 22, 2025